Cytokinetics Stock News & Updates
[WKN: A1W1KK | Symbol: CYTK]
Cytokinetics: H.C. Wainwright Sees 121% Price Potential Following Presentation of Primary Results from the MAPLE-HCM Phase 3 Study
Cytokinetics (CYTK) is a specialist in cardiovascular biopharmaceuticals, and the company recently presented...
Cytokinetics - The Biotech Company Sees a Share Price Jump after Positive Study Results for Aficamten!
Business drivers: Cytokinetics (CYTK) specializes in developing new methods for the treatment of muscular...
5 Rising Biopharma Stocks with over 50% Annual Growth Potential
Dear readers, Last week, I introduced five biopharma stocks that have taken off in recent weeks. It...
Cytokinetics Revolutionizes the Treatment of Heart Muscle Diseases – Aficamten Is a $3.4 Billion Opportunity!
Cytokinetics (CYTK) specializes in developing innovative therapies for treating heart muscle diseases...
Analysts' Top 5 Price Targets of September 2, 2025
Cytokinetics [US23282W6057] Citigroup reaffirms Buy rating and raises the price target from $77...
Stocks in Action USA: Scholastic (SCHL), Cytokinetics (CYTK), Alnylam (ALNY)
Scholastic (SCHL) stock surges: Largest price increase since July 2022 = small hope for a rebound! ...
- ‹
- 1
- ›